Prosecution Insights
Last updated: April 19, 2026

Examiner: MOSHER, ERIC PARKER

Tech Center 1600 • Art Units: 1612

This examiner grants 0% of resolved cases

Performance Statistics

%
Allow Rate
-60.0% vs TC avg
7
Total Applications
Interview Lift
1175
Avg Prosecution Days
Based on 0 resolved cases, 2023–2026

Rejection Statute Breakdown

0%
§101 Eligibility
3.6%
§102 Novelty
25.0%
§103 Obviousness
32.1%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18219922 RATIONAL DESIGN OF THREE-DIMENSIONAL BIODEGRADABLE CORE-UPCONVERSION TETRAGONAL NANODENDRITES WITH ULTRABRIGHT LUMINESCENCE FOR VARIOUS BIOMEDICAL APPLICATIONS Non-Final OA RESEARCH & BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY
18546311 DUAL MODE RADIOTRACER AND THERAPEUTICS Non-Final OA Technische Universität München
18451174 BIODEGRADABLE RADIOPAQUE MICROSPHERE Non-Final OA Varian Medical Systems, Inc.
18519493 MANGANESE-BASED ORGANIC FRAMEWORK AND PREPARATION METHOD AND DRUG DELIVERY METHOD Non-Final OA Hong Kong Centre for Cerebro-Cardiovascular Health Engineering Limited
18496519 CONTRAST AGENT FOR DIAGNOSIS OF VASCULAR DISEASE CONTAINING GADOLINIUM-BASED COMPOUND AS ACTIVE INGREDIENT AND SYNTHESIS METHOD THEREFOR Non-Final OA DAEGU CATHOLIC UNIVERSITY INDUSTRY ACADEMIC COOPERATION FOUNDATION
18546185 BIVALENT FIBROBLAST ACTIVATION PROTEIN LIGANDS FOR TARGETED DELIVERY APPLICATIONS Non-Final OA PHILOCHEM AG
18261493 METHOD FOR PURIFICATION OF RADIOLABELED MACROAGGREGATED HUMAN SERUM ALBUMIN Non-Final OA Trasis S.A.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month